At the time of writing, Encompass Health Corp [EHC] stock is trading at $102.87, up 0.46%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The EHC shares have gain 0.03% over the last week, with a monthly amount glided 1.51%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Encompass Health Corp [NYSE: EHC] stock has seen the most recent analyst activity on October 11, 2024, when KeyBanc Capital Markets initiated its Overweight rating and assigned the stock a price target of $115. Previously, Leerink Partners started tracking the stock with Outperform rating on July 10, 2024, and set its price target to $100. On March 06, 2024, Barclays initiated with a Overweight rating and assigned a price target of $95 on the stock. Barclays started tracking the stock assigning a Equal Weight rating and suggested a price target of $57 on March 14, 2023. UBS initiated its recommendation with a Buy and recommended $98 as its price target on September 24, 2021. Raymond James upgraded its rating to Strong Buy for this stock on August 02, 2021, and upped its price target to $107. In a note dated November 23, 2020, Barclays upgraded an Overweight rating on this stock but restated the target price of $96.
For the past year, the stock price of Encompass Health Corp fluctuated between $64.15 and $104.55. Currently, Wall Street analysts expect the stock to reach $107.5 within the next 12 months. Encompass Health Corp [NYSE: EHC] shares were valued at $102.87 at the most recent close of the market. An investor can expect a potential return of 4.5% based on the average EHC price forecast.
Analyzing the EHC fundamentals
According to Encompass Health Corp [NYSE:EHC], the company’s sales were 5.21B for trailing twelve months, which represents an 11.94% jump. Gross Profit Margin for this corporation currently stands at 0.22% with Operating Profit Margin at 0.16%, Pretax Profit Margin comes in at 0.14%, and Net Profit Margin reading is 0.08%. To continue investigating profitability, this company’s Return on Assets is posted at 0.07, Equity is 0.24 and Total Capital is 0.15. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of1.33.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 101.67 points at the first support level, and at 100.48 for the second support level. However, for the 1st resistance point, the stock is sitting at 103.53, and for the 2nd resistance point, it is at 104.20.
Ratios To Look Out For
It is important to note that Encompass Health Corp [NYSE:EHC] has a current ratio of 1.04. Further, the Quick Ratio stands at 1.04, while the Cash Ratio is 0.16. Considering the valuation of this stock, the price to sales ratio is 1.99, the price to book ratio is 5.29 and price to earnings (TTM) ratio is 24.83.
Transactions by insiders
Recent insider trading involved COLTHARP DOUGLAS E, EVP & Chief Financial Officer, that happened on Aug 13 ’24 when 12260.0 shares were sold. Officer, Douglas Coltharp completed a deal on Aug 13 ’24 to buy 12260.0 shares. Meanwhile, Chief Medical Officer Charbonneau Elissa Joy sold 10000.0 shares on May 24 ’24.
